Cureveda Overview
- Founded
- 2010
- Status
- Out of Business
- Employees
- 3
- Latest Deal Type
- Out of Business
Cureveda General Information
Description
Operator of a biotechnology company intended to develops therapies for the treatment of chronic diseases. The company's biotechnology services include developing small molecules targeting Nrf2 pathway for treatment of chronic obstructive pulmonary disease and other inflammatory disorders, enabling patients to counteract inflammation and cellular dysfunction caused due to oxidative stress.
Contact Information
Website
www.cureveda.com
Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Drug Discovery
Primary Office
- 1450 South Rolling Road
- Halethorpe, MD 21227
- United States
Cureveda Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Out of Business | 01-Sep-2016 | 00000 | Completed | Out of Business | ||
| 2. Grant | 07-Sep-2014 | 00000 | 00000 | Completed | Startup | |
| 1. Accelerator/Incubator | $100K | $100K | Completed | Startup |
Cureveda Executive Team (4)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Rajesh Thimmulappa Ph.D | Co-Founder |
Cureveda Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trial